Screening compound: XKLNZDTWPFEPTL-GFCCVEGCSA-N

Screening compound: XKLNZDTWPFEPTL-GFCCVEGCSA-N
Screening compound: XKLNZDTWPFEPTL-GFCCVEGCSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
XKLNZDTWPFEPTL-GFCCVEGCSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S069-3965

Molecular Formula

C19H22N4O4S (C19 H22 N4 O4 S)

Compound Name

5-{[3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-1-pyrrolidinyl]sulfonyl}-3,3-dimethyl-1,3-dihydro-2H-indol-2-one

IUPAC name

5-{[3-(5-cyclopropyl-124-oxadiazol-3-yl)pyrrolidin-1-yl]sulfonyl}-33-dimethyl-23-dihydro-1H-indol-2-one

SMILES

CC(C)(c(cc(cc1)S(N(CC2)CC2c2noc(C3CC3)n2)(=O)=O)c1N1)C1=O

InChI

InChI=1S/C19H22N4O4S/c1-19(2)14-9-13(5-6-15(14)20-18(19)24)28(25,26)23-8-7-12(10-23)16-21-17(27-22-16)11-3-4-11/h5-6,9,11-12H,3-4,7-8,10H2,1-2H3,(H,20,24)/t12-/m1/s1

InChI Key

XKLNZDTWPFEPTL-GFCCVEGCSA-N

MDL Number (MFCD)

XKLNZDTWPFEPTL-GFCCVEGCSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Indole Derivatives (10091 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • GPCR
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with XKLNZDTWPFEPTL-GFCCVEGCSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound XKLNZDTWPFEPTL-GFCCVEGCSA-N?
Check Price and Availability of XKLNZDTWPFEPTL-GFCCVEGCSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of XKLNZDTWPFEPTL-GFCCVEGCSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for XKLNZDTWPFEPTL-GFCCVEGCSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for XKLNZDTWPFEPTL-GFCCVEGCSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of XKLNZDTWPFEPTL-GFCCVEGCSA-N available by request